DFTX FY 2019 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$6,683

Operating Income

-$468,180

Net Income

-$1M

EPS (Diluted)

$-2.94

Cash Flow

Operating Cash Flow

-$208,119

Free Cash Flow

-$521,576

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3M

Total Liabilities

$198,957

Stockholders' Equity

$3M

Cash & Equivalents

$17,931

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,683	-$6,681	-0.0%
Operating Income	-$468,180	-$861,940	+45.7%
Net Income	-$1M	-$857,944	-30.1%